Research and Evaluation on Drugs and Crime, Fiscal Year 2020

0
590

Funding Opportunity ID: 324020
Opportunity Number: NIJ-2020-17275
Opportunity Title: Research and Evaluation on Drugs and Crime, Fiscal Year 2020
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Law, Justice and Legal Services
Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 16.560
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: See announcement for full eligibility information.
Agency Code: USDOJ-OJP-NIJ
Agency Name: Department of Justice
National Institute of Justice
Posted Date: Jan 30, 2020
Close Date: Apr 20, 2020
Last Updated Date: Jan 30, 2020
Award Ceiling: $1,000,000
Award Floor: $0
Estimated Total Program Funding: $3,000,000
Expected Number of Awards: 5
Description: NIJ's Drugs and Crime Research Program supports rigorous applied research on evidence-based tools, protocols, and policies for state, tribal, and local law enforcement and other criminal justice agencies that address drug trafficking, drug markets, and drug-related violence. The focus of this research solicitation is narcotics-related criminal investigation, prosecution, intelligence, and community surveillance relevant to law enforcement and medicolegal death investigation activities. The proposed FY2020 solicitation's drug priorities are methamphetamine and other stimulants, including diverted pharmaceuticals, illicit drugs and their analogues.
Version: 1





Visit the Official Webpage For More Details on Research and Evaluation on Drugs and Crime, Fiscal Year 2020